Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer

Background: Cisplatin (DDP) is the first-in-class drug for advanced and non-targetable non-small-cell lung Cancer (NSCLC). A recent study indicated that DDP could slightly induce non-apoptotic cell death Ferroptosis, and the cytotoxicity was promoted by Ferroptosis inducer. The agents enhancing the Ferroptosis may therefore increase the Anticancer effect of DDP. Several lines of evidence supporting the use of phytochemicals in NSCLC therapy. Ginkgetin, a bioflavonoid derived from Ginkgo biloba leaves, showed Anticancer effects on NSCLC by triggering Autophagy. Ferroptosis can be triggered by Autophagy, which regulates redox homeostasis. Thus, we aimed to elucidate the possible role of Ferroptosis involved in the synergistic effect of ginkgetin and DDP in Cancer therapy.

Methods: The promotion of DDP-induced Anticancer effects by ginkgetin was examined via a cytotoxicity assay and western blot. Ferroptosis triggered by ginkgetin in DDP-treated NSCLC was observed via a lipid peroxidation assay, a labile iron pool assay, western blot, and qPCR. With Ferroptosis blocking, the contribution of Ferroptosis to ginkgetin + DDP-induced cytotoxicity, the Nrf2/HO-1 axis, and Apoptosis were determined via a luciferase assay, immunostaining, chromatin immunoprecipitation (CHIP), and flow cytometry. The role of Ferroptosis in ginkgetin + DDP-treated NSCLC cells was illustrated by the application of Ferroptosis inhibitors, which was further demonstrated in a xenograft nude mouse model.

Results: Ginkgetin synergized with DDP to increase cytotoxicity in NSCLC cells, which was concomitant with increased labile iron pool and lipid peroxidation. Both these processes were key characteristics of Ferroptosis. The induction of Ferroptosis mediated by ginkgetin was further confirmed by the decreased expression of SLC7A11 and GPX4, and a decreased GSH/GSSG ratio. Simultaneously, ginkgetin disrupted redox hemostasis in DDP-treated cells, as demonstrated by the enhanced ROS formation and inactivation of the Nrf2/HO-1 axis. Ginkgetin also enhanced DDP-induced mitochondrial membrane potential (MMP) loss and Apoptosis in cultured NSCLC cells. Furthermore, blocking Ferroptosis reversed the ginkgetin-induced inactivation of Nrf2/HO-1 as well as the elevation of ROS formation, MMP loss, and Apoptosis in DDP-treated NSCLC cells.

Conclusion: This study is the first to report that ginkgetin derived from Ginkgo biloba leaves promotes DDP-induced Anticancer effects, which can be due to the induction of Ferroptosis.